joining Okay. Thank and everyone. good morning, you, appreciate Todd, us today. you We
quarter third from recent organic as strong growth revenue. projections continued results in driven core as growth activity, well expectations, The leading sequential in our our year-over-year growth to M&A by net businesses continued exceeded both and and
revenue exceeding established to our quarter company third $XX finish another in million, strong a Our net and establishing of the record of end pathway top yet guidance a XXXX.
mission more I finish operational want Life strong to relentless patient X,XXX their employees. than family, numbers will dedication acknowledge incredible Their our to performance now our a satisfaction and Your and thank focus which enable to Live XXXX. Viemed and on
the for HME the want and is exactly home it drill medical doing doesn't morning some what capture earning there substantially that It's bit and avoid Viemed in comfort even we're about the why hospitals of description equipment payers the clinical setting. I believe point patients, down know talk differentiated more place to a versus the in trusted the and day the us from that we Patients home are to heard home this the in is fully that providers care You've providers on matters. and in that providing and costs home. their we're to an lower in treated clear proving to of every out be value want the readmissions home, a systems safety the home payers. trend institutional to that health and time. want
since and operational for satisfaction patient care high-touch, delivering Viemed are home. high-technology our with outcomes, pillars the model. Improving leader care the day efficiency has been in X a
our patient is clear important, ever. increasingly What's it to become environment, and to satisfaction that solutions for address operations patient value-based be care. than coordination. outcomes personalized more when as particularly compliance. and to A Utilizing Engage support and platform today's comes accurate focus advanced critical ultimately need on mention patient proprietary communication to becomes in These provider the patient concerns provide not care us such boost streamline to scalable data is can offering tools to care, needed
the about This the we why should center the been home. our It's of lead we've it. our expect allocated to for patients. offer We're training technology, services social we and the we where continue to capital the to provision investments of in industry ready going, recruiting, be and Viemed. have with is a we're at that we model state the deploying talking RTs future isn't in everything do at This reason
coverage NIV policies support positive the a for for On been Viemed regulatory and of comprehensive emphasizing NCD front, has the advocate for we're signs seeing therapy. XXX.X, objective of industry. the some leading reconsideration
deliver for MA guidelines the the serious appropriate that request believe We to are care. clinical is another that holding plans we've signal NCD seen for they CMS from accountable about
and a facilitate industry will consistent that for business submitted comments on the proactive create to a and The establishing in real and is we've expansion. we patients. positive, been think of this guidelines continued opportunity is uncertainty need reason clear stable for NCD reduce the majority for The on environment and have serve been NCD the those providers
the costs, And efficacy the supports hospitalizations putting improving in resulting of patient research life. there necessity reductions of outcomes. patients the improved in device NIV, and significant data medical quality is the their immediately on and The for exhibits
industry We've leadership supported comments. provide submitted trade the sponsored role NCD through in and or through to of cited other our Viemed comments a continue have on the We'll much and research the associations.
momentum products increase to the reimbursement would has there been highlight that for movement areas. adjustment consideration those be for at recent relief. means. dead that any support, XX-XX in certain the legislative recent by some year. like also serving with This Medicare and providers on the areas reimbursements of I'd backed certain end up positive isn't rate some should for Recall It adds this it
restoration relief performance As financial for the in we've be noted positive before, of this would XXXX.
the have future we've years. in leading our on in me updates a number QX both on as vent business experienced a and patients. sequential a The was continued business. good in The we patients of quarters usually reinforces now with positive vent some quarter this display sequential QX Let increase active business. and as indicator vent in to turn again That of strength X.X% outlook produced increase the we is on for is brief growth the XXX-plus
overhaul growth Those vent billings. higher vent patient so is has and utilization completed we in the processes the resulted strong One efforts operational driving the our vent in reasons earlier internal of year. been
sales with reps monthly to the place quarter producing our maintain we've prior recruitment an The accelerating been growth. were rep and to setups XX% in sales organic of as an they new industry-leading impact having structure implementation, we is in the well. With what sales discussed put compared per last increase average
in expect We more to to on this effort have report QX.
it's I believe pretty we In the from quarter our GLP-Xs Based makes conclusive what the sleep on around sleep is narrative that say not overall GLP-X growth business. ResMed business, a the so terms we've what difference all of in a are others of can drugs. and seen far, impeding
in weight. bringing before, for appears as apnea to be into treatment noted sleep we they fact, and patients it disorders other more As lose
sleep therapies climb. GLP-X both loss, apnea weight obesity to and Despite use for continue the of rates increasing
with moderate sleep weight that alone. patients to provides benefits with loss either research For obesity-related greater apnea, combining treatment consistently therapy PAP than shows severe
GLP-X X XX.X% rates, patients reveals Real-world to with increased more OSA data years PAP adherence X medications start by likely prescribed higher at evidenced are that setup. PAP post resupply therapy orders significantly and
we're amount units, our sleep the The improvement in of in patients, lines with and seeing increasing We're in up seeing home business. what sequential sentiment CPAP growth research orders published resupply we only scratched currently this our we've can the of sleep growth. is XX% of of contribute what total surface Even though tests. contributing QX, our business overall revenue to as believe and
each outlined revenue track of last we're still easing our joint this this, Alabama on for growth plans. million our We X approximately incremental our on. our acquisition, made a We're with annualized is We've plan this And way test into plans. as when $X for the of integration the East case made that's future like venture quarters. JVs path we we are and progress
JV to We expect more the to out at the year-end. have report on
strong our to delivered. opportunities on a could payers robust providers our that also they've hit on relationships earned M&A could the quarter. this to adding greater we've expand We've and value could our throughout Our services remains team strategic patients businesses. new already efficiencies. and with and our core executed complementary focus pleased I'm These with build regularly Overall, goals, scale with challenged we've and through enhance how pipeline
the momentum XXXX With on for a built have our in of XXXX. record-breaking positive in quarters top lot EBITDA ever will quarter into that highest fourth up of feed we QX, quarter
with our a The provide increasing vent strong together sleep growth, patient resupply patient growth. of organic and base sleep business
We have letting up. no intention of
the a in XXXX. are stronger finishing We laser-focused a strong exit for velocity on year on which will internally note, provide
on and I'll quarter, Todd. back financial the more call operational For our the turn over for to results
